FierceBiotech ٩ ديسمبر ٢٠٢٥ Novartis pens $1.7B immuno-dermatology pact with AI-enabled British biotech
Endpoints News ٨ ديسمبر ٢٠٢٥ #ASH25: Will a biotech’s pivot away from obesity let it compete with Novartis in leukemia?
BioPharma Dive ٨ ديسمبر ٢٠٢٥ Terns drug shows potential to challenge Novartis’ blockbuster leukemia treatment
BioPharma Dive ٢٦ نوفمبر ٢٠٢٥ Novartis cuts hundreds of jobs; Novo’s dual-acting diabetes drug heading to Phase 3